Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma

NCT00366106 is registered in ClinicalTrials.gov with Accelerated Community Oncology Research Network as lead sponsor.

NCT NCT00366106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00366106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma
Lead sponsor
Accelerated Community Oncology Research Network
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
March 31, 2011
Enrollment
32 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma